Global Metabolic Health Roundtable Series
Addressing the Public Health Threat of MASLD/MASH and other major NCDs

- Duration
- 22/04/2025 - 31/10/2025
- Coordinator
- ISGlobal
- Funded by
- Boehringer Ingelheim, Echosens, Novo Nordisk and the CUNY Graduate School of Public Health and Health Policy
The Global Metabolic Health Roundtable (GMHR) Series: Addressing the Public Health Threat of MASLD/MASH and other major NCDs was initiated by the Barcelona Institute for Global Health (ISGlobal) Public Health Liver Group and is led in partnership with the Healthy Livers Healthy Lives Coalition (HLHL). Together, we aim to foster dialogue, knowledge exchange, and policy action to address the public health threat of metabolic diseases, building on HLHL's global research and action priorities for steatotic liver disease (SLD), and the importance of recognising chronic liver disease, with a focus on MASLD/MASH, as a major NCD.
This series will consist of a virtual meeting in each of the following three regions in June 2025:
- Latin America and the Caribbean
- The Middle East and North Africa
- Asia and the Pacific
In each meeting, a multidisciplinary stakeholder group will convene to discuss regional priorities while contributing to a broader international agenda on metabolic health. A particular focus will be on metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) to elevate their recognition as a priority alongside the more widely addressed metabolic diseases (e.g. diabetes, cancer, and cardiovascular disease) within the global public health agenda.
The lively discussions form part of preparations for the United Nations General Assembly (UNGA) High-level Meeting (HLM) on NCDs in September 2025, and an in-person GMHR side-event in New York City during the UNGA HLM. The series also complements ongoing side-events in Geneva taking place during the World Health Assembly in May 2025 and will culminate with a session at the World Health Summit in October 2025.
For those interested in applying to participate or learning more, please contact publichealthliver@isglobal.org with the subject line: “Global Metabolic Health Roundtable Series Query”.
The initiative is endorsed by The City University of New York Graduate School of Public Health and Health Policy (CUNY SPH), Global Think-tank on Steatotic Liver Disease, International Liver Cancer Movement (ILCM), Fatty Liver Alliance, MASH Cities coalition, and UNITE, the Parliamentarians Network for Global Health.
Our Team
Our Team
-
Leire Agirre Research Assistant
-
Anthony Armenta Jr Health Communications Officer
-
Delfina Boudou Global Health Project Manager
-
Jeffrey Lazarus Head of the Public Health Liver Group
-
Lisa Rice Project Manager
-
Trenton White Predoctoral Fellow
Other projects
Evaluación de la eficacia del ácido acetilsalicílico a dosis bajas en la prevención de los efectos maternos y perinatales adversos en mujeres embarazadas infectadas por el SARS-CoV-2
FLAVOBAC
Nuevas moléculas de oro coordinadas con flavonoides contra bacterias patógenas multirresistentes prioritarias
EpiGen
Building Scalable Pathogen Genomic Epidemiology in Ethiopia
ENDÈMIC
Community knowledge generation through scientific culture, urban ecology and art
Más allá de la supresión vírica del VIH: un cuarto noventa para mejorar la salud de personas viviendo con el VIH en España
Project Code: PI20/01654
Desarrollo de dos nuevas estrategias terapéuticas (inhibidores de bombas de expulsion y ARN antisentido) activos frente a bacterias mutliresistentes
Nuevos complejos de oro (III) frente a bacterias multirresistentes
Project Code: DTS21/00004
Estudio de la propagación de bacterias y genes de resistencia a los antibióticos en el ciclo integral del agua, en el área metropolitana de Barcelona
Propagación de la resistencia en aguas